How is Crohn’s Disease Diagnosed in 2026

Diagnosing Crohn’s disease requires a multi-layered approach combining blood work, stool analysis, endoscopic imaging, and tissue biopsy. According to 2025 ACG guidelines, fecal calprotectin testing now serves as a frontline screening tool before invasive procedures. Most patients undergo colonoscopy with biopsy to confirm inflammation patterns, though newer biomarker panels and imaging technologies are reducing diagnostic delays. Understanding these methods helps patients advocate for timely, accurate diagnosis and appropriate treatment pathways.

Quick Answer: The Multi-Test Framework for Confirming Crohn’s Disease

When patients first ask how Crohn’s disease is diagnosed, they often expect a single definitive test. The reality is more complex. Gastroenterologists use a systematic process that rules out other conditions while building evidence for inflammatory bowel disease. No single test confirms Crohn’s on its own diagnosis requires correlation across multiple data points from different testing modalities.

According to the American College of Gastroenterology, GI clinical guidelines have evolved significantly in their diagnostic recommendations for Crohn’s disease. The 2025 guidelines position fecal calprotectin as the initial screening step, which has fundamentally changed how quickly patients move through the diagnostic pathway. This stool-based test helps identify whether inflammation is present before committing to more invasive procedures.

@keyframes hoox-lf-in-hoox-f-7926e210-65c0-453b-b118-ff8e0d-top {
from { opacity: 0; transform: translateY(8px); }
to { opacity: 1; transform: translateY(0); }
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top {
width: 100%;
max-width: 100%;
box-sizing: border-box;
display: flex;
flex-direction: column;
gap: 20px;
margin: 48px 0;
padding: 32px 28px;
border-radius: 16px;
background: #ffffff;
color: #111111;
font-family: inherit;
border: 1px solid #E2E8F0;
animation: hoox-lf-in-hoox-f-7926e210-65c0-453b-b118-ff8e0d-top 0.3s cubic-bezier(0.16, 1, 0.3, 1);
direction: inherit;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-form-header {
display: flex;
flex-direction: column;
gap: 8px;
text-align: center;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-form-header h2 {
margin: 0;
font-size: 1.5em;
font-weight: 700;
line-height: 1.3;
color: #111111;
border: none;
padding: 0;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-form-header p {
margin: 0;
font-size: 1em;
line-height: 1.6;
color: #64748B;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top form[data-hx-form] {
margin: 0;
display: flex;
flex-direction: column;
gap: 14px;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-field-wrap {
position: relative;
width: 100%;
box-sizing: border-box;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-field-wrap input {
width: 100%;
box-sizing: border-box;
height: 44px;
padding-inline-start: 42px;
padding-inline-end: 14px;
border: 1px solid #E2E8F0;
border-radius: 10px;
font-size: 14px;
color: #111111;
font-family: inherit;
background-color: #F8FAFC;
transition: border-color 0.15s ease, box-shadow 0.15s ease, background-color 0.15s ease;
outline: none;
direction: inherit;
text-align: start;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-field-wrap input::placeholder {
color: #94A3B8;
opacity: 1;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-field-wrap input:focus {
background-color: #FFFFFF;
border-color: #0077B6,#00B4D8,#90E0EF;
box-shadow: 0 0 0 3px rgba(15, 23, 42, 0.08);
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-field-icon {
position: absolute;
top: 0;
bottom: 0;
inset-inline-start: 0;
width: 42px;
display: flex;
align-items: center;
justify-content: center;
pointer-events: none;
color: #94A3B8;
transition: color 0.15s ease;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-field-wrap:focus-within .hoox-field-icon {
color: #0077B6,#00B4D8,#90E0EF;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top button[type=”submit”] {
width: 100%;
height: 44px;
margin-top: 4px;
border: none;
border-radius: 10px;
background: #0077B6,#00B4D8,#90E0EF;
color: #FFFFFF;
font-size: 14px;
font-weight: 600;
cursor: pointer;
transition: opacity 0.15s ease, transform 0.15s ease, box-shadow 0.15s ease;
box-shadow: 0 1px 2px 0 rgba(0, 0, 0, 0.05);
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top button[type=”submit”]:hover {
opacity: 0.94;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top button[type=”submit”]:active {
transform: scale(0.99);
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top button[type=”submit”]:disabled {
opacity: 0.6;
cursor: not-allowed;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-disclaimer {
margin: 0;
text-align: center;
font-size: 12px;
line-height: 1.5;
color: #94A3B8;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-disclaimer a {
color: inherit;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-disclaimer a:hover {
text-decoration: none;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-success {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
position: relative;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-confetti {
position: absolute;
inset: 0;
overflow: visible;
pointer-events: none;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-confetti span {
position: absolute;
top: 50%;
left: 50%;
width: 7px;
height: 11px;
background: var(–hoox-c);
border-radius: 2px;
opacity: 0;
animation: hoox-confetti-burst 0.9s ease-out forwards;
animation-delay: var(–hoox-d, 0s);
}

@keyframes hoox-confetti-burst {
0% { opacity: 1; transform: translate(-50%, -50%) rotate(0deg) scale(1); }
100% { opacity: 0; transform: translate(calc(-50% + var(–hoox-tx)), calc(-50% + var(–hoox-ty))) rotate(var(–hoox-rz)) scale(0.5); }
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-success-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #ECFDF5;
display: flex;
align-items: center;
justify-content: center;
font-size: 26px;
line-height: 1;
animation: hoox-success-pop 0.4s cubic-bezier(0.34, 1.56, 0.64, 1);
}

@keyframes hoox-success-pop {
from { opacity: 0; transform: scale(0.5); }
to { opacity: 1; transform: scale(1); }
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-success-text {
margin: 0;
text-align: center;
font-size: 15px;
font-weight: 600;
line-height: 1.5;
color: #111111;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-disabled-state {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
text-align: center;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-disabled-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #F1F5F9;
display: flex;
align-items: center;
justify-content: center;
color: #64748B;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-disabled-text {
margin: 0;
font-size: 14px;
line-height: 1.6;
color: #64748B;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-disabled-text a {
color: inherit;
font-weight: 600;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-top .hoox-disabled-text a:hover {
text-decoration: none;
}

Patients often feel overwhelmed by the number of tests required, but each serves a specific purpose in building a complete diagnostic picture. For those seeking common questions about IBD diagnosis, understanding this sequence helps reduce anxiety and improves communication with healthcare providers.

• Fecal calprotectin test: First-line screening to detect intestinal inflammation non-invasively
• Comprehensive blood panel: Identifies systemic inflammation markers and nutritional deficiencies
• Colonoscopy with biopsy: Gold standard for visualizing colon inflammation and obtaining tissue samples
• CT or MRI enterography: Advanced imaging for small bowel involvement assessment
• Upper endoscopy: Evaluates esophagus, stomach, and duodenum when upper GI symptoms present
• Capsule endoscopy: Alternative for visualizing small intestine areas unreachable by standard endoscopy

Why Fecal Calprotectin Changed the Diagnostic Timeline in 2025-2026

The fecal calprotectin test represents one of the most significant advances in Crohn’s diagnosis methods over the past decade. Calprotectin is a protein released by neutrophils white blood cells that rush to sites of inflammation. When intestinal inflammation is present, calprotectin levels in stool rise dramatically, providing a non-invasive biomarker that correlates well with active disease.

Before calprotectin testing became standard, patients often endured longer diagnostic delays. The traditional pathway required patients to demonstrate persistent symptoms before physicians would recommend colonoscopy. Now, an elevated calprotectin result provides objective evidence that justifies moving forward with invasive testing sooner. As noted by GI professional guidelines, this testing approach has reduced median time to diagnosis for many inflammatory bowel disease patients.

However, calprotectin has limitations. It detects inflammation but cannot specify the cause infections, NSAID use, and other conditions also elevate levels. Additionally, calprotectin primarily reflects colonic inflammation and may miss isolated small bowel Crohn’s disease. Patients with primarily small intestinal involvement might have normal calprotectin despite significant disease activity.

Diagnostic Pathway	Traditional Approach (Pre-2020)	Calprotectin-First (2025-2026)
Initial screening	Symptom documentation only	Fecal calprotectin + symptom review
Time to colonoscopy referral	3-6 months of documented symptoms	Elevated calprotectin expedites referral
Unnecessary procedures	Higher rate of normal colonoscopies in IBS patients	Reduced invasive procedures for non-inflammatory conditions
Diagnostic confidence	Relied heavily on symptom presentation	Objective biomarker supports clinical decisions
Small bowel disease detection	Often delayed until complications arise	Normal calprotectin with symptoms triggers imaging

For patients exploring natural support for inflammatory bowel disease, calprotectin also provides a way to monitor whether interventions correlate with reduced intestinal inflammation over time.

Colonoscopy Remains the Gold Standard for Colon-Based Crohn’s Confirmation

Despite advances in biomarker testing, colonoscopy with biopsy remains essential for definitive Crohn’s disease detection in the colon. During the procedure, a gastroenterologist inserts a flexible tube with a camera through the rectum to examine the entire colon and terminal ileum the last section of small intestine where Crohn’s frequently appears.

Patients typically receive sedation, making the procedure itself relatively comfortable. Most report little memory of the actual examination. The significant challenge lies in preparation: patients must consume a large volume of laxative solution to completely clear the colon, usually starting the day before. This preparation is unpleasant but essential residual stool obscures the mucosal surface and can hide inflammation, leading to false-negative results.

What makes colonoscopy irreplaceable is the ability to take targeted biopsies. The appearance of inflammation during colonoscopy helps differentiate Crohn’s from ulcerative colitis. Crohn’s characteristically shows patchy, skip-lesion patterns with areas of normal tissue between inflamed segments. Ulcerative colitis typically shows continuous inflammation starting from the rectum and extending proximally. Biopsy samples examined under a microscope can reveal granulomas clusters of immune cells that, when present, strongly suggest Crohn’s disease.

The procedure typically takes 30-45 minutes, with patients resting afterward as sedation wears off. Most can resume normal activities the following day, though some patients benefit from herbal support for colon inflammation during the recovery period and beyond.

Blood Work Reveals Systemic Inflammation Markers and Nutritional Deficiencies

Blood tests serve multiple roles in Crohn’s diagnosis methods. They don’t confirm the disease independently, but they provide essential supporting evidence while identifying complications that require attention. Understanding what each test reveals helps patients interpret their results more effectively.

• C-reactive protein (CRP): An acute-phase protein that rises with systemic inflammation. Elevated CRP supports an inflammatory process but is nonspecific many conditions increase CRP.
• Erythrocyte sedimentation rate (ESR): Another inflammation marker, though slower to rise and fall than CRP. Some patients have elevated ESR with normal CRP or vice versa.
• Complete blood count (CBC): Reveals anemia from chronic gastrointestinal bleeding or nutrient malabsorption. Elevated white blood cells may indicate active inflammation or infection.
• Vitamin B12 level: Low B12 suggests terminal ileum involvement, as this region absorbs B12. Crohn’s affecting this area impairs absorption.
• Iron studies: Iron deficiency anemia is common in Crohn’s from chronic blood loss and impaired iron absorption in inflamed duodenum and jejunum.
• Vitamin D level: Low vitamin D correlates with disease severity and is the most common vitamin deficiency in IBD patients.
• Comprehensive metabolic panel: Assesses kidney function, liver function, and electrolyte balance important baselines before starting certain medications.

Patients often find that blood work provides the first objective evidence something is wrong beyond symptoms. While these markers don’t diagnose Crohn’s specifically, they build the clinical picture that justifies further investigation. Reading patient experiences with diagnosis journeys helps many individuals understand they’re not alone in navigating this often-frustrating process.

How Advanced Imaging Differentiates Small Bowel vs. Colon Crohn’s

Not all Crohn’s disease affects the colon. Approximately 30% of patients have disease limited to the small bowel, which colonoscopy cannot fully visualize. Advanced imaging fills this diagnostic gap, allowing physicians to assess the entire digestive tract without invasive exploration.

MRI enterography has become the preferred imaging modality for small bowel Crohn’s in 2026. It uses magnetic fields rather than radiation, making it safer for younger patients and those requiring repeated imaging. Patients drink contrast fluid that distends the small intestine, allowing clear visualization of wall thickening, strictures, and fistulas. The detailed images reveal patterns characteristic of Crohn’s transmural inflammation inflammation that penetrates through all layers of the intestinal wall.

CT enterography provides similar visualization but uses ionizing radiation. While faster and more readily available in some settings, cumulative radiation exposure concerns limit its use. Patients requiring multiple follow-up scans over years of disease management generally benefit from MRI to reduce lifetime radiation exposure.

Capsule endoscopy offers another option for difficult-to-visualize small bowel regions. Patients swallow a pill-sized camera that captures thousands of images during its transit through the digestive tract. This technology excels at detecting subtle mucosal changes in areas unreachable by standard endoscopy. However, capsule endoscopy cannot take biopsies, and there’s a risk the capsule could become trapped in narrowed strictures necessitating surgical removal.

When upper GI symptoms suggest disease involving the stomach, duodenum, or esophagus, upper endoscopy (EGD) provides direct visualization and biopsy capability. Some patients require both upper and lower endoscopy for comprehensive evaluation. Those considering integrative approaches to digestive health should discuss how imaging results might influence their overall management strategy.

Imaging Modality	Best For	Radiation	Biopsy Capability
MRI Enterography	Small bowel assessment, young patients, repeated imaging	None	No
CT Enterography	Emergency settings, patients with contraindications to MRI	Yes	No
Capsule Endoscopy	Obscure bleeding, subtle small bowel lesions	None	No
Upper Endoscopy (EGD)	Upper GI symptoms, duodenal biopsy	None	Yes
PET-CT	Assessing disease activity in complex cases	Yes (combined)	No

Step-by-Step: What to Expect During Your Crohn’s Disease Diagnostic Journey

The path from first symptoms to confirmed diagnosis varies significantly between patients. Some navigate this journey in weeks; others spend months or even years seeking answers. Understanding the typical sequence helps patients advocate for appropriate testing while managing expectations about timelines.

1. Initial consultation: Your primary care physician evaluates symptoms and orders preliminary blood work. Document symptom frequency, triggers, and impacts on daily life thoroughly this documentation influences referral urgency.
2. GI referral: Wait times vary by location and insurance authorization. Prepare a detailed symptom history to maximize consult efficiency.
3. Stool testing: Fecal calprotectin and pathogen testing rule out infections. Collect samples properly improper handling can invalidate results.
4. Blood panel expansion: Specialized testing for IBD markers, nutritional deficiencies, and baseline organ function before procedure scheduling.
5. Pre-procedure authorization: Insurance pre-authorization can take days to weeks. Some plans require documented elevated calprotectin before approving colonoscopy.
6. Colonoscopy scheduling: Includes detailed preparation instructions. Follow these exactly inadequate prep often requires procedure rescheduling.
7. Biopsy results: Pathology typically takes 7-14 days. Results confirm diagnosis and classify disease pattern.
8. Treatment planning: Post-diagnosis consultation reviews findings and establishes management approach based on disease location, severity, and patient factors.

Throughout this process, patients benefit from tracking symptoms meticulously. Many find smartphone apps helpful for documenting bathroom frequency, pain levels, and dietary correlations. This information helps physicians assess disease patterns and treatment response over time. Learning more about our journey supporting IBD patients provides context for what to expect after diagnosis.

Key Takeaways: Securing an Accurate Crohn’s Diagnosis Faster

Understanding how Crohn’s disease is diagnosed empowers patients to participate actively in their healthcare journey. The diagnostic process has improved significantly with calprotectin screening, but challenges remain particularly for patients with small bowel disease or atypical presentations.

• Document symptoms in detail before appointments: Frequency, severity, triggers, and impact on daily life provide crucial clinical context that objective tests cannot capture.
• Request calprotectin testing early: If symptoms suggest IBD, this non-invasive test can expedite specialist referral and justify colonoscopy sooner.
• Prepare thoroughly for colonoscopy: Inadequate bowel preparation is the leading cause of repeat procedures follow instructions completely even when unpleasant.
• Advocate for comprehensive imaging: If colonoscopy is normal but symptoms persist, small bowel imaging may detect disease colonoscopy cannot reach.
• Consider second opinions for complex cases: IBD specialty centers have additional expertise for diagnostically challenging presentations.

Patients navigating this journey benefit from knowing they’re not alone. Support resources and explore natural IBD support options can provide additional tools while working through the diagnostic process and beyond.

Frequently Asked Questions About Crohn’s Disease Diagnosis

Can Crohn’s disease be diagnosed with a blood test alone?

No. Blood tests indicate inflammation but cannot confirm Crohn’s disease independently. Blood markers like CRP and ESR rise in many inflammatory conditions, making them nonspecific. Definitive diagnosis requires direct visualization of intestinal inflammation through endoscopy or imaging, plus tissue biopsy confirmation. Blood work supports the diagnostic picture and identifies complications but never stands alone as sufficient for diagnosis.

How long does it take to get a Crohn’s diagnosis in 2026?

Typically 2-6 months from symptom onset. Calprotectin-first screening has reduced median diagnostic time compared to previous years. However, delays still occur due to specialist availability, insurance authorization requirements, and appointment scheduling. Patients with clear biomarker elevations move through faster; those with normal calprotectin but persistent symptoms may face extended investigation involving small bowel imaging and capsule endoscopy.

Can I have Crohn’s with a normal colonoscopy?

Yes. Crohn’s disease can affect the small intestine exclusively, areas beyond colonoscopy reach. Normal colonoscopy with persistent symptoms warrants small bowel imaging through MRI enterography or capsule endoscopy. Additionally, early or mild disease may show subtle changes that are easy to miss. Skip lesions with normal intervening tissue can also result in sampling error if biopsies target unaffected areas.

What happens if calprotectin is elevated but colonoscopy is normal?

Further investigation is needed. Elevated calprotectin indicates intestinal inflammation but doesn’t localize it. Small bowel imaging examines areas colonoscopy cannot reach. Other causes include infections, medication effects, and other inflammatory conditions. Repeat calprotectin testing over time tracks whether elevation persists or normalizes. Consistently elevated results with normal endoscopy may indicate very early disease or small bowel involvement requiring additional imaging.

Should I continue natural supplements during diagnostic testing?

Consult your physician before stopping or starting supplements. Some supplements can affect test results or interact with procedure sedation. Anti-inflammatory herbs may reduce inflammation markers, potentially masking disease activity during diagnostic evaluation. Others might increase bleeding risk during biopsies. Be transparent with your gastroenterologist about all supplements, herbs, and over-the-counter products you’re taking so they can advise appropriately.

How accurate is the combination of calprotectin and colonoscopy for diagnosis?

High accuracy for colonic Crohn’s detection. Combining calprotectin screening with colonoscopy and biopsy achieves strong diagnostic confidence when disease affects the colon. The combination reduces unnecessary procedures in calprotectin-negative patients while expediting colonoscopy for those with positive results. False negatives remain possible, particularly in small bowel disease. The complete IBD FAQ resource addresses additional questions about specific testing scenarios.

@keyframes hoox-lf-in-hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom {
from { opacity: 0; transform: translateY(8px); }
to { opacity: 1; transform: translateY(0); }
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom {
width: 100%;
max-width: 100%;
box-sizing: border-box;
display: flex;
flex-direction: column;
gap: 20px;
margin: 48px 0;
padding: 32px 28px;
border-radius: 16px;
background: #ffffff;
color: #111111;
font-family: inherit;
border: 1px solid #E2E8F0;
animation: hoox-lf-in-hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom 0.3s cubic-bezier(0.16, 1, 0.3, 1);
direction: inherit;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-form-header {
display: flex;
flex-direction: column;
gap: 8px;
text-align: center;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-form-header h2 {
margin: 0;
font-size: 1.5em;
font-weight: 700;
line-height: 1.3;
color: #111111;
border: none;
padding: 0;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-form-header p {
margin: 0;
font-size: 1em;
line-height: 1.6;
color: #64748B;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom form[data-hx-form] {
margin: 0;
display: flex;
flex-direction: column;
gap: 14px;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-field-wrap {
position: relative;
width: 100%;
box-sizing: border-box;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-field-wrap input {
width: 100%;
box-sizing: border-box;
height: 44px;
padding-inline-start: 42px;
padding-inline-end: 14px;
border: 1px solid #E2E8F0;
border-radius: 10px;
font-size: 14px;
color: #111111;
font-family: inherit;
background-color: #F8FAFC;
transition: border-color 0.15s ease, box-shadow 0.15s ease, background-color 0.15s ease;
outline: none;
direction: inherit;
text-align: start;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-field-wrap input::placeholder {
color: #94A3B8;
opacity: 1;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-field-wrap input:focus {
background-color: #FFFFFF;
border-color: #0077B6,#00B4D8,#90E0EF;
box-shadow: 0 0 0 3px rgba(15, 23, 42, 0.08);
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-field-icon {
position: absolute;
top: 0;
bottom: 0;
inset-inline-start: 0;
width: 42px;
display: flex;
align-items: center;
justify-content: center;
pointer-events: none;
color: #94A3B8;
transition: color 0.15s ease;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-field-wrap:focus-within .hoox-field-icon {
color: #0077B6,#00B4D8,#90E0EF;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom button[type=”submit”] {
width: 100%;
height: 44px;
margin-top: 4px;
border: none;
border-radius: 10px;
background: #0077B6,#00B4D8,#90E0EF;
color: #FFFFFF;
font-size: 14px;
font-weight: 600;
cursor: pointer;
transition: opacity 0.15s ease, transform 0.15s ease, box-shadow 0.15s ease;
box-shadow: 0 1px 2px 0 rgba(0, 0, 0, 0.05);
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom button[type=”submit”]:hover {
opacity: 0.94;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom button[type=”submit”]:active {
transform: scale(0.99);
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom button[type=”submit”]:disabled {
opacity: 0.6;
cursor: not-allowed;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-disclaimer {
margin: 0;
text-align: center;
font-size: 12px;
line-height: 1.5;
color: #94A3B8;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-disclaimer a {
color: inherit;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-disclaimer a:hover {
text-decoration: none;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-success {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
position: relative;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-confetti {
position: absolute;
inset: 0;
overflow: visible;
pointer-events: none;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-confetti span {
position: absolute;
top: 50%;
left: 50%;
width: 7px;
height: 11px;
background: var(–hoox-c);
border-radius: 2px;
opacity: 0;
animation: hoox-confetti-burst 0.9s ease-out forwards;
animation-delay: var(–hoox-d, 0s);
}

@keyframes hoox-confetti-burst {
0% { opacity: 1; transform: translate(-50%, -50%) rotate(0deg) scale(1); }
100% { opacity: 0; transform: translate(calc(-50% + var(–hoox-tx)), calc(-50% + var(–hoox-ty))) rotate(var(–hoox-rz)) scale(0.5); }
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-success-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #ECFDF5;
display: flex;
align-items: center;
justify-content: center;
font-size: 26px;
line-height: 1;
animation: hoox-success-pop 0.4s cubic-bezier(0.34, 1.56, 0.64, 1);
}

@keyframes hoox-success-pop {
from { opacity: 0; transform: scale(0.5); }
to { opacity: 1; transform: scale(1); }
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-success-text {
margin: 0;
text-align: center;
font-size: 15px;
font-weight: 600;
line-height: 1.5;
color: #111111;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-disabled-state {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
text-align: center;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-disabled-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #F1F5F9;
display: flex;
align-items: center;
justify-content: center;
color: #64748B;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-disabled-text {
margin: 0;
font-size: 14px;
line-height: 1.6;
color: #64748B;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-disabled-text a {
color: inherit;
font-weight: 600;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-7926e210-65c0-453b-b118-ff8e0d-bottom .hoox-disabled-text a:hover {
text-decoration: none;
}